搜索临床试验以:TCM-700C
总计1149个结果
-
National Cancer Institute (NCI)完全的
-
Vifor PharmaPierrel Research Europe GmbH完全的
-
Ege UniversityFresenius Medical Care North America完全的
-
St. Petersburg State Pavlov Medical University完全的
-
Saladax Biomedical, Inc.University of Maryland, Baltimore; The Feinstein Institutes for Medical Research完全的
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
MetroHealth Medical CenterNational Institute on Drug Abuse (NIDA)完全的
-
Children's Hospital of Philadelphia完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)尚未招聘
-
Taipei Veterans General Hospital, Taiwan尚未招聘
-
Opexa Therapeutics, Inc.终止临床孤立综合征 | 多发性硬化症,复发缓解美国
-
Alice BertainaCalifornia Institute for Regenerative Medicine (CIRM)招聘中
-
Johns Hopkins Bloomberg School of Public HealthAnnamalai University完全的
-
The Hong Kong Polytechnic UniversityFood and Health Bureau, Hong Kong招聘中
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Hospices Civils de Lyon完全的Moderate to Severe Hearing Loss | Indication of Middle Ear Implant (MET)
-
SOLTI Breast Cancer Research Group完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)主动,不招人复发性胶质母细胞瘤 | 复发性恶性胶质瘤 | 难治性恶性胶质瘤 | 复发性 WHO III 级神经胶质瘤 | 复发性 WHO II 级神经胶质瘤 | 难治性胶质母细胞瘤 | 难治性 WHO II 级神经胶质瘤 | 难治性 WHO III 级神经胶质瘤美国
-
Baxter Healthcare Corporation完全的Sinus Implant Reconstruction德国
-
We The Village, Inc.National Institute on Drug Abuse (NIDA); Public Health Management Corporation完全的
-
Erasmus Medical CenterLudwig Institute for Cancer Research; Dutch Cancer Society; Stichting Coolsingel Rotterdam grant; Jan Ivo Stichting grant招聘中
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology主动,不招人
-
Michael LuebbertUniversity Hospital Freiburg未知